Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients
Articolo
Data di Pubblicazione:
2016
Citazione:
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients / Omarini, Claudia; Guaitoli, Giorgia; Noventa, Silvia; Andreotti, Alessia; Gambini, Anna; Palma, E; Papi, Simona; Tazzioli, Giovanni; Balduzzi, Sara; Dominici, Massimo; Cascinu, Stefano; Piacentini, Federico. - In: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. - ISSN 0748-7983. - (2016), pp. 1-6. [10.1016/j.ejso.2016.09.020]
Abstract:
The optimal time interval between the end of neoadjuvant systemic therapy (NST) and breast surgery is still unclear. It is not known if a delay in surgery might influence the benefit of primary chemotherapy. The aim of this study is to evaluate the relationship between time to surgery (TTS) and survival outcomes.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Breast cancer; Neoadjuvant chemotherapy; Time to surgery; pCR
Elenco autori:
Omarini, Claudia; Guaitoli, Giorgia; Noventa, Silvia; Andreotti, Alessia; Gambini, Anna; Palma, E; Papi, Simona; Tazzioli, Giovanni; Balduzzi, Sara; Dominici, Massimo; Cascinu, Stefano; Piacentini, Federico
Link alla scheda completa:
Pubblicato in: